| Davis, Michael C |
NCT03406884: The CHILD Trial: Hypoplastic Left Heart Syndrome Study. |
|
|
| Completed | 1 | 25 | US | c-kit+ cells, Autologous c-kit-positive cells (c-kit+ cells) | Joshua M Hare | Hypoplastic Left Heart Syndrome | 07/24 | 07/24 | | |
NCT00243776: Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development |
|
|
| Recruiting | N/A | 600 | US | | Emory University, National Heart, Lung, and Blood Institute (NHLBI) | Congenital Heart Disease, Tetralogy of Fallot | 12/25 | 12/25 | | |
| Kaushal, Sunjay |
ELPISII, NCT04925024: Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. |
|
|
| Recruiting | 2 | 38 | US | Lomecel-B medicinal signaling cells | Longeveron Inc., National Heart, Lung, and Blood Institute (NHLBI), Ann & Robert H Lurie Children's Hospital of Chicago, The University of Texas Health Science Center, Houston | Hypoplastic Left Heart Syndrome | 06/26 | 08/26 | | |
| Active, not recruiting | 1 | 70 | US | Longeveron Mesenchymal Stem Cells (LMSCs), Placebo | Longeveron Inc. | ARDS, Human, Covid19 | 06/24 | 07/25 | | |
| Deatrick, Kristopher |
| Recruiting | 2 | 20 | US | Emergency preservation and resuscitation, Standard resuscitation | University of Maryland, Baltimore, Cook County Health | Cardiac Arrest From Trauma | 12/25 | 12/25 | | |
| Active, not recruiting | 1 | 70 | US | Longeveron Mesenchymal Stem Cells (LMSCs), Placebo | Longeveron Inc. | ARDS, Human, Covid19 | 06/24 | 07/25 | | |
NCT03406884: The CHILD Trial: Hypoplastic Left Heart Syndrome Study. |
|
|
| Completed | 1 | 25 | US | c-kit+ cells, Autologous c-kit-positive cells (c-kit+ cells) | Joshua M Hare | Hypoplastic Left Heart Syndrome | 07/24 | 07/24 | | |
